Suppr超能文献

在不进行液体复苏的情况下从失血中存活。

Surviving blood loss without fluid resuscitation.

作者信息

Shults Christian, Sailhamer Elizabeth A, Li Yongqing, Liu Baoling, Tabbara Malek, Butt Muhammad Umar, Shuja Fahad, Demoya Marc, Velmahos George, Alam Hasan B

机构信息

Department of Surgery, Division of Trauma, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Trauma. 2008 Mar;64(3):629-38; discussion 638-40. doi: 10.1097/TA.0b013e3181650ff3.

Abstract

BACKGROUND

Patients with massive blood loss often die before delivery of definitive care, especially in austere environments. Strategies that can maintain life during evacuation and transport to higher levels of care may be lifesaving. We have previously shown that administration of histone deacetylase inhibitors (HDACI) enhance gene transcription through specific modifications of DNA-associated histone proteins. Furthermore, it protects against organ damage when given before hemorrhage. The current experiment was done to test whether administration of HDACI after lethal hemorrhage, without fluid resuscitation, would improve outcome by creating a pro-survival phenotype.

METHODS

Seventy-two male Wistar-Kyoto rats (n = 12 per group) were subjected to 60% blood volume loss for 1 hour (40% arterial bleed for 10 minutes and 20% venous bleed for 50 minutes). After hemorrhage, animals were randomized to receive one of two HDACI: (1) valproic acid (VPA, 300 mg/kg in 0.25 mL saline), or (2) suberoyanilide hydroxamic acid (SAHA, 7.5 mg/kg in 0.25 mL saline). Control groups included (3) no hemorrhage (Sham), (4) no resuscitation (NR), (5) 0.9% saline resuscitation, 3 times the volume of shed blood (NS), and (6) vehicle control, 0.25 mL 0.9% saline (VEH). Hemodynamic data were recorded continuously, and physiologic parameters were measured serially. Survival for 3 hours was the primary endpoint for this experiment.

RESULTS

Nonresuscitated shock (NR group) was highly lethal and only 25% of the animals survived for 3 hours. Administration of HDACI after hemorrhage (without fluid resuscitation) significantly improved survival (75% and 83% in VPA and SAHA groups, respectively, p < 0.05 vs. NR). Survival was 40%, 100%, and 100% in the VEH, Sham, and NS resuscitation groups, respectively.

CONCLUSIONS

This study demonstrates that post-shock administration of HDACI can significantly improve early survival in a highly lethal model of hemorrhagic shock, even in the absence of conventional fluid resuscitation. This approach may be especially relevant for austere environments where fluids are in limited supply, such as a battlefield.

摘要

背景

大出血患者往往在获得确定性治疗之前就死亡了,尤其是在条件简陋的环境中。能够在转运至更高水平医疗机构的过程中维持生命的策略可能会挽救生命。我们之前已经表明,给予组蛋白去乙酰化酶抑制剂(HDACI)可通过对与DNA相关的组蛋白进行特定修饰来增强基因转录。此外,在出血前给予该药物可防止器官损伤。当前的实验旨在测试在致死性出血后且不进行液体复苏的情况下给予HDACI是否会通过产生促生存表型来改善结局。

方法

72只雄性Wistar - Kyoto大鼠(每组12只)经历60%血容量丢失1小时(40%动脉出血10分钟,20%静脉出血50分钟)。出血后,动物被随机分为接受两种HDACI之一:(1)丙戊酸(VPA,300 mg/kg溶于0.25 mL盐水中),或(2)辛二酰苯胺异羟肟酸(SAHA,7.5 mg/kg溶于0.25 mL盐水中)。对照组包括(3)未出血(假手术组),(4)未复苏(NR组),(5)0.9%盐水复苏,失血量3倍体积(NS组),以及(6)溶剂对照组,0.25 mL 0.9%盐水(VEH组)。连续记录血流动力学数据,并连续测量生理参数。3小时存活是本实验的主要终点。

结果

未复苏休克(NR组)具有高度致死性,只有25%的动物存活3小时。出血后给予HDACI(不进行液体复苏)显著提高了存活率(VPA组和SAHA组分别为75%和83%,与NR组相比p < 0.05)。VEH组、假手术组和NS复苏组的存活率分别为40%、100%和100%。

结论

本研究表明,在出血性休克的高致死模型中,休克后给予HDACI可显著提高早期存活率,即使在没有传统液体复苏的情况下也是如此。这种方法对于诸如战场等液体供应有限的简陋环境可能特别适用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验